Zobrazeno 1 - 10
of 15
pro vyhledávání: '"John P. Gleysteen"'
Autor:
Richa Jain, E. Ritter Sansoni, Jacqueline Angel, John P. Gleysteen, D. Neil Hayes, Adepitan A. Owosho
Publikováno v:
Dentistry Journal, Vol 11, Iss 10, p 229 (2023)
Salivary duct carcinoma with rhabdoid features (SDC-RF) is a rare form of salivary gland neoplasm that was recently described. We report a case of SDC-RF of the parotid gland with loss of E-cadherin and decreased β-catenin expression in a 73-year-ol
Externí odkaz:
https://doaj.org/article/5fb6f35d7ae146578c38c159bbeaed19
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 6, Iss 5, Pp 940-947 (2021)
Abstract Objective To evaluate the feasibility and outcomes of porcine submucosal allograft (Biodesign Sinonasal Repair Graft [Cook Medical, Bloomington, IN]) in oral cavity and oropharynx reconstruction after ablative surgery. Methods We conducted a
Externí odkaz:
https://doaj.org/article/006badb0df8344b1b545497e84f8092f
Autor:
Adepitan A. Owosho, Katherine DeColibus, Beverly Hedgepeth, Burton C. Wood, Ritter E. Sansoni, John P. Gleysteen, David L. Schwartz
Publikováno v:
Dentistry Journal, Vol 11, Iss 5, p 136 (2023)
This narrative review addresses the role of a dentist in the management of oncology patients, highlighting the oral complications that arise in head and neck radiation oncology patients and medical oncology patients. The prevention and management of
Externí odkaz:
https://doaj.org/article/4a42c03c6cbd40a79e9a261983b3b353
Publikováno v:
Laryngoscope Investigative Otolaryngology
Laryngoscope Investigative Otolaryngology, Vol 6, Iss 5, Pp 940-947 (2021)
Laryngoscope Investigative Otolaryngology, Vol 6, Iss 5, Pp 940-947 (2021)
Objective To evaluate the feasibility and outcomes of porcine submucosal allograft (Biodesign Sinonasal Repair Graft [Cook Medical, Bloomington, IN]) in oral cavity and oropharynx reconstruction after ablative surgery. Methods We conducted a prospect
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 131:e71-e80
Osteosarcoma of the jaw (OSJ) is a rare malignancy, accounting for less than 1% of head and neck malignancies. OSJ can arise as a primary malignancy or secondary to locoregional radiation treatment. Radiologically, these tumors show large, destructiv
Autor:
Walter J. Humann, Chad A. Nieri, Madhu Mamidala, John P. Gleysteen, L. Madison Michael, Jeffrey Sorenson, Brian T. Fowler, Sanjeet V. Rangarajan
Publikováno v:
31st Annual Meeting North American Skull Base Society.
Autor:
Laith Al-Qamachi, Hemantha K. Amarasinghe, Peter E. Andersen, Kevin Arce, Varun Arya, Tomer Avraham, Richard L. Bakst, Lauren E. Basile, Andrew D. Beckler, R. Bryan Bell, Sandeep Bhuta, Carlo B. Bifulco, Gido Bittermann, Keith E. Blackwell, Angel Blanco, Alexander M. Bobinskas, Caroline Brammer, Lawrence E. Brecht, James Brown, Chris J. Butterworth, Eric R. Carlson, Keith A. Chadwick, Srinivasa R. Chandra, Allen Cheng, Scott Claiborne, Daniel R. Clayburgh, Marka R. Crittenden, Brendan D. Curti, Derfel ap Dafydd, Roi Dagan, Camilla Dawson, Eric J. Dierks, Jasjit K. Dillon, Donita Dyalram, Sean P. Edwards, David A. Elliott, Mererid Evans, Adam P. Fagin, Carole Fakhry, Mark B. Faries, Zipei Feng, Rui P. Fernandes, Jay K. Ferrell, Bernard A. Fox, Clifton D. Fuller, G.E. Ghali, John P. Gleysteen, Kathryn A. Gold, James Good, Jennifer R. Grandis, Donna J. Graville, Neil D. Gross, Aaron Grossberg, Shan Guo, Bronwyn Hamilton, Eric K. Hansen, Heidi J. Hansen, Bruce H. Haughey, Richard E. Hayden, Joseph I. Helman, David L. Hirsch, John M. Holland, Katherine A. Hutcheson, Megan J. Hyers, Matthew Idle, James E. Jackson, Scharukh Jalisi, Newell W. Johnson, Terry M. Jones, Deepak Kademani, Joseph R. Kelley, Cyrus Kerawala, Dongsoo David Kim, Tamar A. Kotz, Hirofumi Kuno, Moni Abraham Kuriakose, Susan E. Langmore, Rom Leidner, Jamie P. Levine, Christopher Loh, Sapna Lohiya, Joshua E. Lubek, Andrew J. Lyons, Joann Marruffo, Robert E. Marx, Marco Matos, Austin Mattox, Avanti Mehrotra, James C. Melville, Marc C. Metzger, Brett A. Miles, Krzysztof J. Misiukiewicz, Abdallah S.R. Mohamed, Casian Monaco, James Murphy, Nima Nabavizadeh, Mohammed Nadershah, Thomas H. Nagel, Kate Newbold, Dimitrios Nikolarakos, Kurt Nisi, Robert A. Ord, Larry M. Over, Sara I. Pai, Andrew D. Palmer, Sat Parmar, Ashish A. Patel, Ketan Patel, JoanneM. Patterson, Daniel Petrisor, Phillip Pirgousis, Jesse R. Qualliotine, Francesco M.G. Riva, Samuel J. Rubin, Osamu Sakai, Andrew Salama, Joshua S. Schindler, Rainer Schmelzeisen, Steven K. Seung, Jonathan Shum, Felix Sim, Ryan J. Smart, John T. Stranix, Janakiraman Subramanian, Mohan Suntharalingam, Krishnakumar Thankappan, James Phillip Thomas, David Tighe, Khaled A. Tolba, Scott H. Troob, Minh Tam Truong, Ramzey Tursun, Brent B. Ward, Amber L. Watters, Mark K. Wax, Richard M. Webster, Andrew Weinberg, Hong D. Xiao, Yavuz Yildirim, Yedeh Ying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e655b459715d768ea359125419001fc9
https://doi.org/10.1016/b978-0-323-26568-3.01002-2
https://doi.org/10.1016/b978-0-323-26568-3.01002-2
Autor:
Kurt R. Zinn, Eben L. Rosenthal, J. Scott Magnuson, J. Robert Newman, Kirk Withrow, Joni B. Skipper, John P. Gleysteen
Publikováno v:
Technology in Cancer Research & Treatment. 7:61-66
Optical fluorescent technology has the potential to deliver real time imaging of cancer into the operating room and the clinic. To determine the efficacy of fluorescently labeled anti-vascular endothelial growth factor (VEGF) antibody to be used as a
Autor:
Renee A. Desmond, John P. Gleysteen, Joni B. Skipper, Kirk Withrow, Kurt R. Zinn, Eben L. Rosenthal, Ahmad Safavy
Publikováno v:
Otolaryngology–Head and Neck Surgery. 137:729-734
Objective The aim of this study is to determine the efficacy of indocyanine green (ICG) conjugated to antiepidermal growth factor receptor antibody (cetuximab) to image head and neck cancer. Study Design Mice (n = 3) were injected with unconjugated I
Autor:
Ryan D. Duncan, J. Scott Magnuson, John P. Gleysteen, Kurt R. Zinn, Joni B. Skipper, Eben L. Rosenthal
Publikováno v:
Cancer Biology & Therapy. 6:1192-1196
Objective: Combining the therapeutic and diagnostic properties of targeted antibodies may improve clinical assessment of disease with limited added toxicity during treatment. Methods: Mice (n=10) were xenografted with SCC-1 tumor cells and then treat